NCT05314764 Cefiderocol Pharmacokinetics in Adult Patients With Cystic Fibrosis Status COMPLETED Phase PHASE4
NCT05295524 Description of the Short-term Effects of KAFTRIO® by Continuous Monitoring With the PHEAL-CR-K Application in Real Life in Patients With Cystic Fibrosis Eligible for KAFTRIO® Treatment Status UNKNOWN Phase NA
NCT05276960 Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patients With CF Status COMPLETED Phase PHASE4
NCT05274269 Evaluation of Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis Subjects Without an F508del Mutation Status COMPLETED Phase PHASE3
NCT05267418 Effects of Automated Oxygen Titration Alone or With High Flow Nasal Therapy on Dyspnea and Exercise Tolerance Status TERMINATED Phase NA
NCT05251467 A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CF Status COMPLETED Phase N/A
NCT05249322 Study of Satisfaction of Patients and Care Providers for an Alternate Follow-up With In-hospital Consults and Tele-consult for Patients With Cystic Fibrosis Status UNKNOWN Phase NA
NCT05239611 Feasibility of Home-based Exercise Program for Adults With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT05225805 Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT05206097 Determinants of Daily Physical Activity Level in Patients With Cystic Fibrosis - Pilot Study Protocol Status ACTIVE_NOT_RECRUITING Phase NA
NCT05200429 Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators on People With CF Status RECRUITING Phase N/A
NCT05195216 Psychosocial Factors and Quality of Life in the Effect of Fear of COVID-19 With Cystic Fibrosis Status COMPLETED Phase N/A